Myeloid cells are a broad family of blood and tissue cells that arise from a shared ancestor in the bone marrow and carry out most of the body’s front-line defense, housekeeping, and repair work. The family includes neutrophils, monocytes, macrophages, dendritic cells, eosinophils, basophils, and even red blood cells and platelets. The hematopoietic lineage splits into two main branches, the myeloid and the lymphoid, with the myeloid arm defined by a common myeloid progenitor and every cell type that descends from it.1PubMed Central. Myeloid Cell Origins, Differentiation, and Clinical Implications If lymphoid cells (your T cells and B cells) are the precision-guided missiles of immunity, myeloid cells are the rapid-response infantry, the field medics, and the cleanup crew rolled into one.
Where Myeloid Cells Come From
All blood cells trace back to hematopoietic stem cells in the bone marrow. These stem cells first become multipotent progenitors, which then commit to either the lymphoid path (eventually producing T cells, B cells, and natural killer cells) or the myeloid path. The decision point is the common myeloid progenitor, a cell that can still become any myeloid type but has closed the door on becoming a lymphocyte.2PubMed Central. Stem cell biology is population biology: differentiation of hematopoietic multipotent progenitors to common lymphoid and myeloid progenitors From there, further branching produces the enormous variety of myeloid cells your body needs: the short-lived neutrophils churned out by the billions each day, the monocytes circulating in your blood ready to be called into tissues, the megakaryocytes that bud off platelets for clotting, and the red blood cell precursors that keep you oxygenated.
This lineage tree is not just a textbook curiosity. When something goes wrong at a particular branching point, the consequences show up as specific diseases. A mutation early in the myeloid progenitor stage can lead to acute myeloid leukemia, while a defect in a later branch might affect only one cell type. Understanding where each cell comes from helps explain why certain diseases cluster together and why treatments sometimes affect blood counts in unexpected ways.
The Major Players
The myeloid family is large, and each member has a distinct job. Here are the ones that matter most for understanding what myeloid cells actually do in your body.
- Neutrophils: The most abundant white blood cell in your bloodstream. They are first responders to infection, rushing to the site within hours and killing bacteria through engulfment, toxic chemicals, and a dramatic defense called NETosis, in which the neutrophil ejects its own DNA as a sticky web studded with antimicrobial proteins to trap and kill microbes.3PubMed Central. NETosis: Molecular Mechanisms, Role in Physiology and Pathology Neutrophils live only a day or two, so your marrow produces them continuously.
- Monocytes and macrophages: Monocytes patrol the blood. When they enter tissues, environmental signals shape them into macrophages with functions tailored to that specific tissue. The same starting cell can become a pro-inflammatory fighter or a wound-healing remodeler depending on the local signals it receives.4PubMed Central. From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
- Dendritic cells: Sentinels that capture bits of pathogens in the tissues, carry them to lymph nodes, and present them to T cells, effectively telling the adaptive immune system what to attack.5PubMed. Antigen presentation and T cell stimulation by dendritic cells
- Eosinophils and basophils: Rarer cells involved in parasite defense and allergic reactions. Basophils are a major source of the signaling molecule IL-4 during allergic and parasitic responses, and eosinophils can release toxic granules that damage large parasites too big to be swallowed by a single cell.6PubMed Central. IgE, Mast Cells, Basophils, and Eosinophils These cells share overlapping but non-redundant roles in allergy and anti-parasite defense.7PubMed. Mast cells, basophils and eosinophils: From allergy to cancer
- Red blood cells and platelets: Often overlooked as myeloid cells, but they descend from the same common myeloid progenitor. Platelets bud off from giant precursor cells called megakaryocytes, and red blood cells lose their nuclei during development to become pure oxygen-delivery vehicles.
How Myeloid Cells Detect Threats
Your myeloid cells do not wait for instructions from T cells or B cells before acting. They carry their own surveillance equipment in the form of pattern recognition receptors, proteins on their surface and inside them that detect molecular signatures common to groups of pathogens. Toll-like receptors and inflammasomes, for example, recognize patterns found on bacteria, viruses, and fungi, as well as danger signals released by damaged host cells.8PubMed Central. Host innate immune responses to sepsis This system is fast but broad: it does not distinguish between one strain of bacteria and another the way a T cell can. What it does is buy time, activating inflammation and killing invaders in the first hours while the slower adaptive immune system gears up.
Some pattern recognition receptors are surprisingly specialized. The C-type lectin receptor langerin, found on certain antigen-presenting cells, recognizes sugar structures on the surface of a wide range of pathogens including viruses like HIV, fungi, and mycobacteria. Interestingly, the sugar-binding preferences of langerin differ substantially between species, a reminder that the innate immune system has been fine-tuned by evolution to match the specific threats each species faces.9Journal of Biological Chemistry. Bacterial Polysaccharide Specificity of the Pattern Recognition Receptor Langerin Is Highly Species-dependent
Once a threat is detected, the classic myeloid response is phagocytosis: the cell physically engulfs the microbe, seals it inside a compartment, and digests it with enzymes and reactive oxygen species. This process is so central to immunity that it was one of the first immune mechanisms ever observed, when Elie Metchnikoff watched cells in starfish larvae surround a foreign rose thorn back in 1882.10PubMed Central. EVOLUTION OF MYELOID CELLS Pathogens, of course, have not sat idle. Many have evolved strategies to block or subvert phagocytosis, either preventing ingestion, stalling the digestive process, or even escaping from the compartment entirely.11PubMed Central. Control of Phagocytosis by Microbial Pathogens
Dendritic Cells and the Bridge to Adaptive Immunity
Dendritic cells deserve their own spotlight because they connect the fast, innate myeloid world to the precise, adaptive lymphoid world. In their immature state, dendritic cells sit in tissues and actively sample their surroundings, gulping up material through macropinocytosis and using receptors to grab pathogens. Once they capture something foreign, they chop it into small protein fragments and load those fragments onto specialized display molecules on their surface.12Cell. Regulation of T Cell Immunity by Dendritic Cells – Section: DC Maturation: Assembling Packets of Information for T Cells
The dendritic cell then migrates to a lymph node, where it presents these fragments to T cells. If a T cell recognizes the fragment, it activates, multiplies, and goes to work. This interaction is the ignition switch for most adaptive immune responses. It can also lead to tolerance, teaching T cells not to attack self-tissues, depending on the context.5PubMed. Antigen presentation and T cell stimulation by dendritic cells Dendritic cells are also capable of a process called cross-presentation, where material captured from outside the cell is routed to a pathway that normally handles internally produced proteins, allowing dendritic cells to activate killer T cells against threats they have never been directly infected by.13PubMed. Antigen recognition and presentation by dendritic cells
Not All Macrophages Come from Blood
For decades, the assumption was straightforward: monocytes leave the blood, enter tissues, and become macrophages. That picture has been overhauled. Many tissue-resident macrophages turn out to originate not from adult bone marrow at all, but from embryonic precursors that seeded the tissues before birth. In mammals, these cells arise from early yolk sac progenitors during embryonic development and establish themselves in organs during the process of organ formation, persisting into adulthood.14PubMed Central. Physiology and diseases of tissue-resident macrophages
Research in mice has shown that Kupffer cells in the liver, microglia in the brain, Langerhans cells in the skin, and alveolar macrophages in the lungs all originate from yolk sac progenitors that colonize the fetal liver early in development and then spread to their target organs.15PubMed Central. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors Most of these populations maintain themselves locally for the life of the animal, with little to no replacement from blood monocytes. Microglia, for instance, are essentially a self-renewing population sealed behind the blood-brain barrier. Alveolar macrophages in the lungs may see some gradual replacement with age, but the others remain remarkably stable.16Immunity. What Is a Myeloid Cell and What Does It Do? – Section: Contribution of YS Macrophages to Tissue-Resident Macrophage Populations
This matters because it means the macrophages keeping watch in your brain or liver are not interchangeable with the monocyte-derived macrophages rushing to a wound. They have different developmental histories, different self-renewal programs, and likely different functional tendencies shaped by a lifetime of interaction with their home tissue.
Myeloid Cells in Wound Healing
When you cut yourself, the first wave of immune cells to arrive at the wound includes neutrophils and monocyte-derived macrophages. These early macrophages are predominantly inflammatory: they clear debris, kill bacteria, and send out alarm signals. But as the wound progresses from the inflammatory phase to the repair phase, the macrophages in the area shift their behavior dramatically. Research in mouse skin wounds has shown that early-phase wound macrophages rely heavily on glycolysis, a fast but inefficient way of burning fuel that supports their aggressive inflammatory stance. By contrast, later-phase macrophages switch to mitochondrial oxidative metabolism, expanding their mitochondrial networks and ramping up oxygen consumption to support the energy-intensive work of tissue remodeling and blood vessel formation.17Cell Metabolism. Mitochondrial metabolism coordinates macrophage remodelling and angiogenesis during wound healing
This metabolic switch is not just a passive consequence of calming down. It actively drives the macrophage’s change in behavior, a theme that shows up repeatedly in myeloid biology: how a cell burns its fuel shapes what it does.18PubMed Central. Energy metabolic pathways control the fate and function of myeloid immune cells
When Myeloid Cells Fuel Disease
The same inflammatory power that makes myeloid cells effective against infections can become destructive when it is not properly shut off. In rheumatoid arthritis, for instance, myeloid cells in the joint lining get trapped in sustained inflammatory feedback loops, driving ongoing tissue damage and disability.19Clinical and Experimental Immunology. Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells More broadly, the way monocyte and macrophage subpopulations polarize toward inflammatory or regulatory states plays a key role in the progression of multiple autoimmune diseases, with the balance between these states often determining whether the disease stabilizes or worsens.20Frontiers in Immunology. The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review
Myeloid cells are central to cardiovascular disease as well. In atherosclerosis, monocytes infiltrate artery walls, gorge themselves on oxidized cholesterol, and transform into foam cells, the lipid-stuffed macrophages that form the core of arterial plaques. Single-cell studies have identified distinct subtypes of these monocyte-derived foam cells within plaques, including inflammatory populations that likely drive plaque instability and rupture.21PubMed Central. Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms Heart attacks and strokes are, in a very real sense, diseases of myeloid cells behaving badly inside blood vessel walls.
Myeloid Cells and Cancer
Tumors are not just masses of cancer cells. They exist within a complex ecosystem called the tumor microenvironment, and myeloid cells are among its most important residents. Tumors actively reprogram infiltrating myeloid cells, converting them from potential defenders into allies. Tumor-associated macrophages and myeloid-derived suppressor cells do not just passively stand by; they actively block T cell function, promote the growth of new blood vessels to feed the tumor, encourage cancer cell spread, and support the cancer stem cell population.22PubMed Central. Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
Myeloid-derived suppressor cells are a particularly heterogeneous group that accumulates in many cancer types and powerfully suppresses antitumor immunity.23iLIVER. Myeloid-derived suppressor cells in cancer These cells and tumor-associated macrophages often work in concert: blood monocytes enter the tumor, polarize into immunosuppressive macrophages, and collectively create an environment where the immune system’s killer cells cannot do their job.24PubMed Central. Fatty Acid Metabolism in Myeloid-Derived Suppressor Cells and Tumor-Associated Macrophages: Key Factor in Cancer Immune Evasion
This has made myeloid cells a major focus of cancer immunotherapy research. Current T cell-focused therapies like checkpoint inhibitors work well in some cancers but fail in others, often because the myeloid compartment of the tumor is too suppressive for T cells to function even after they are “unblocked.” Newer strategies aim to reprogram tumor myeloid cells by targeting receptors and signaling pathways that drive their suppressive behavior, shifting them from tumor-promoting to tumor-fighting phenotypes.25PubMed Central. Targeting Myeloid Cells for Cancer Immunotherapy Approaches under clinical investigation include antibodies and small molecules aimed at receptors such as CSF1R, immune checkpoints on myeloid cells, and metabolic pathways that these cells rely on.26PubMed Central. Targeting myeloid cells to improve cancer immune therapy
Trained Immunity
Immunology textbooks used to draw a hard line: the innate immune system (including myeloid cells) responds the same way each time, while the adaptive immune system (T and B cells) learns and remembers. That distinction has softened considerably. Myeloid cells can undergo a form of long-term functional reprogramming called trained immunity, where exposure to one infection or stimulus primes them to respond more vigorously to a completely different stimulus encountered later.
The mechanism is not genetic mutation but epigenetic modification: chemical changes to how DNA is packaged and read. When innate immune cells, or even the bone marrow stem cells that produce them, encounter certain stimuli, they acquire epigenetic marks that keep immune genes in a more accessible, ready-to-fire state. This is paired with a metabolic shift toward glycolysis that provides the energy intermediates needed for a stronger inflammatory response.27PubMed Central. The causes and consequences of trained immunity in myeloid cells Remarkably, this memory can be passed from stem cells to their offspring: trained hematopoietic stem cells produce macrophages that are epigenetically primed for a more robust response, even though those macrophages never encountered the original stimulus themselves.28PubMed Central. Lnc-ing Trained Immunity to Chromatin Architecture
Trained immunity may help explain why certain vaccines, like BCG, appear to offer some nonspecific protection against unrelated infections. It also has a darker side: inappropriately trained myeloid cells might fuel chronic inflammatory diseases by overreacting to innocuous signals.
Myeloid Cancers
When the myeloid lineage itself becomes cancerous, the result is a group of blood cancers collectively called myeloid neoplasms. The most aggressive of these is acute myeloid leukemia, in which immature myeloid cells multiply uncontrollably in the bone marrow, crowding out normal blood cell production. The genetic landscape of AML is now known to involve mutations across a wide range of categories, including genes controlling epigenetic regulation, cell signaling, transcription, RNA splicing, and more.29PubMed Central. Driver mutations in acute myeloid leukemia Many of these same mutations show up along a continuum that begins with clonal hematopoiesis, a condition where a single stem cell clone gradually takes over a larger share of blood cell production in otherwise healthy older adults, and can progress through pre-leukemic states before reaching full-blown leukemia.
The myelodysplastic syndromes represent another group of myeloid neoplasms where the bone marrow produces abnormal, poorly functioning blood cells. These conditions often transform into AML over time. Chronic myeloid leukemia, myeloproliferative neoplasms, and other disorders round out the spectrum, all connected by their origin in the myeloid progenitor compartment.
Myeloid Cells and Aging
As you age, the myeloid compartment changes in ways that contribute to a general decline in immune function. The term “inflammaging” captures a core feature of the aged immune system: a chronic, low-level inflammatory state driven in large part by myeloid cells that have become less precise in their responses. Age-dependent alterations affect the differentiation of myeloid progenitors and the way mature myeloid cells respond to both internal and external threats.30PubMed Central. Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases
Neutrophils from older adults, for instance, tend to be less efficient at migrating to infection sites and less effective at killing bacteria. Macrophages may skew toward pro-inflammatory behavior without the corresponding ability to resolve inflammation once the threat is handled. This myeloid drift contributes to the frailty and increased susceptibility to infections, cardiovascular disease, and cancer that characterize aging. It also intersects with clonal hematopoiesis: as certain stem cell clones expand with age, the myeloid cells they produce may carry mutations that further promote inflammation, creating a self-reinforcing cycle.
An Evolutionary Perspective
Myeloid-like cells are not a recent invention. Phagocytic cells that detect and engulf foreign material exist in organisms separated from us by hundreds of millions of years of evolution. Metchnikoff’s original 1882 observation of phagocytosis was made in starfish larvae, invertebrates that lack anything resembling an adaptive immune system but still mount effective cellular immune responses.10PubMed Central. EVOLUTION OF MYELOID CELLS The core myeloid toolkit of phagocytosis, pattern recognition, and inflammation management was refined over an enormous timescale. Vertebrates then layered the adaptive immune system on top of this ancient foundation, adding the precision of T and B cell responses without discarding the myeloid cells that do most of the heavy lifting. Your neutrophils and macrophages are the descendants of a defense strategy that was already working before anything with a backbone existed.